Table 2.

Recent progress and status of patient-derived tumor models.

Therapeutic Moiety/Combination	Target	Cancer Type	Animal Type	Reference
Erlotinib	EGFR	Glioblastoma	Athymic nude mice	[100]
Gefitinib and Enzalutamide	Androgen receptor and EGFR	non-small cell lung cancer and Prostate cancer	Chick chorioallantoic membrane (CAM)	[101]
Apatinib, Regorafenib, Cabozantinib, Ramucirumab	VEGFR2	Gastric cancers	Zebrafish	[102]
Ramucirumab	Her2, FGFR2, cMet	Gastric cancers	BALB/c nude mice	[103]
Bortezomib	CDK4 and MDM2	Liposarcoma	Mice	[104]
Pembrolizumab	PD-1/PD-L1	Soft Tissue Sarcoma	NSG mice	[105]
Erdafitinib	FGFR	Metastatic prostate cancer	Male mice	[106]
β-elemene and cisplatin-coloaded liposomes	Codelivery to reverse MDR	Lung cancer	C57BL/6 mice	[107]